Med CM News

SIGA Technologies announced that they are expected to break cover on the size/possibility of US orders for their smallpox antiviral shortly.

SIGA Technologies announced that they are expected to break cover on the size/possibility of US orders for their smallpox antiviral shortly. In a less Delphic utterance Emergent Biosolutions announced that it had been advised by the Office of the Biomedical Advanced Research and Development Authority (BARDA) that the Request for Proposal (RFP) for the procurement of rPA vaccines has been cancelled in favor of a Broad Agency Announcement (BAA) for rPA vaccine development.

BARDA decided that after a technical panel determined that no vaccine developers could meet the Project Bioshield requirement for having a product ready in 8 years. This decision has no impact on the CDC contract to provide 14.5 million doses of Biothrax into the strategic reserve.


--------------------------------------------------------------------------------

Tags: Contract

Our Current Sponsors

  • 908 Devices
  • Airboss
  • Argon
  • Avon
  • Battelle
  • Biofire Idaho
  • Bruker
  • Bw Tek
  • Cap Force 1 Decon 01
  • CQC
  • Cristanini
  • Decon Seven Systems
  • DQE
  • Dxterity
  • Emergent Biosol
  • Endeavor Roborics
  • Ecotest
  • Federal Resources
  • First Line Technology
  • Flir
  • Futurtech
  • Hameln
  • Metrohm Raman
  • NBC sys
  • Proengin
  • Qinetiq
  • RSDecon
  • Tex Shield
  • Wl Gore